# 6790
Yesterday The Lancet published a commentary by ECDC Director Dr Marc Sprenger, and the head of Influenza and other Respiratory Viruses Programme Dr Angus Nicoll, on the often-disappointing effectiveness of influenza vaccines – particularly among elderly and high-risk recipients.
In many ways their concerns mirror those expressed in CIDRAP’s recent Comprehensive Influenza Vaccine Initiative (CCIVI) report (see CIDRAP: The Need For `Game Changing’ Flu Vaccines) – which they cite - that also calls for improved flu vaccine technology.
The ECDC has a short summary of the Lancet article (see below), and a link (free, but registration required) to the Lancet Article.
Better seasonal influenza vaccines to improve coverage in Europe
18 Dec 2012
ECDC
To achieve increased and sustainable influenza vaccine coverage in Europe, the effectiveness of seasonal influenza vaccines should be improved, especially for the clinical risk groups and older people. In their Lancet commentary published yesterday, ECDC Director Dr Marc Sprenger and Head of Influenza and other Respiratory Viruses Programme Dr Angus Nicoll look at effectiveness studies of seasonal influenza vaccines and suggest several areas for improvement.
While effectiveness of the influenza vaccine is influenced by the type of viruses circulating each season, independent observational studies led by ECDC and other European experts also show that, in Europe, seasonal vaccine effectiveness in the old and clinical risk groups has regularly been less than 70%. In 2009, the Council of the EU pledged regional political commitment to improve vaccine coverage, and set a national target of 75% coverage for older age groups (ie, aged 65 years and older), individuals with chronic ill health, and health-care workers. From the public perspective and a public health standpoint, more effective vaccines are needed to encourage their use and reach towards the target of vaccination coverage.
Importantly, since vaccine effectiveness is highest among healthy adults, a way to protect the most vulnerable groups – young children, older people and those with chronic diseases – could be by vaccinating those around them. Therefore, it is especially important for healthcare workers to get vaccinated (external link), to protect their patients as well as themselves.
The authors conclude by stating that vaccination remains the single most effective preventive measure against seasonal influenza, and the use of present vaccines should be strongly advocated among those for whom they are recommended.
The Lancet Infectious Diseases, 'Low effectiveness undermines promotion of seasonal influenza vaccine', (open access, registration needed)
Related Post:
- Anticipating The Flu Season Down Under
- ACP Calls For Health Care Worker Immunizations
- Branswell On Flu Vaccine Matches
- Flu Vaccine Still Available, But Spot Shortages Exist
- What is Metoclopramide - Side Effects
- Combat the Stomach Flu Symptoms with Prochlorperazine
- CDC Statement On This Year’s Flu Activity
- HPA: Flu Activity In The UK
- Flu Reports From Around The Nation
- Stomach Flu Symptoms - Ugly Truth
- Stomach Flu - What to Eat!?
- FluView, FluWatch, And WHO Flu Surveillance Reports
- Early Flu Cases Begin To Emerge
- Novartis Fluad And Agriflu Vaccines Suspended In Canada
- Rhode Island Adopts New Flu Vaccination Requirements For HCPs
- Lancet: Public Response To The H1N1 Pandemic Of 2009
- A WHO Flu Review
- WHO: Southern Hemisphere 2013 Flu Vaccine Composition
- FluView Week 37 & Variant Flu Update
- NPM12: Giving Preparedness A Shot In The Arm
- The Return Of H1N1v
- CDC Variant Flu Update & FluView Week 35
- Osterholm: Time To Close The Pig Barns
- EID Journal: Flu In Healthy-Looking Pigs
- ECDC Influenza Virus Characterization
- ECDC: Updated Novel Coronavirus Risk Assessment
- ECDC Updates Their Coronavirus Risk Assessment
- ECDC Risk Assessment: Dengue In Madeira
- WHO Europe: Revising Pandemic Preparedness Plans
- ECDC: Multidrug Resistant Infections Increasing In Europe
- Global Flu Surveillance Updates
- Updated ECDC Risk Assessment On Coronavirus
- ECDC: Influenza Virus Characterization – Sept 2012
- EID Journal: Challenges To Defining TDR-TB
- ECDC: Coronavirus `does not signal the start of a new SARS outbreak’
- ECDC Report: Narcolepsy In Association With Pandemic Flu Vaccination
- ECDC Risk Assessment On DR Congo Ebola Outbreak
- H3N2v: CDC Update & ECDC Risk Assessment
- ECDC: Climatic Suitability For Dengue Transmission in Europe
- Updating The Cambodian `Mystery’ Illness
- ECDC: Risk Assessment On Edinburgh Legionella Outbreak
- ECDC Response Plan To Multi-Drug Resistant Gonorrhea
- ECDC: Communicable Disease Threats -Week 23
- How The ECDC Will Spend Your Summer Vacation
- ECDC: Mapping Disease Vectors
- ECDC: Status & Importance Of Invasive Mosquito Breeds In Europe
- WHO-ECDC: Joint Report On Tuberculosis In Europe
- ECDC: Annual Risk Assessment On Seasonal Flu 2011-2012
- Study: The Benefits Of Antiviral Therapy During the 2009 Pandemic
- Peter Sandman On the CCIVI Vaccine Report
- CIDRAP: The Need For `Game Changing’ Flu Vaccines
- CID Study: Effectiveness Of 2010-11 Flu Vaccine
- NIVW: Dec 4th – 10th, 2011
- CIDRAP: A Comprehensive Flu Vaccine Effectiveness Meta-Analysis
- Study: Obesity, Influenza & Immunity
- Pediatrics: Effectiveness Of A Single Adjuvanted Pandemic Flu Shot In Children
- Growing Diversity Of The H1N1 Virus
- BMJ: Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine
- Eurosurveillance: Another Pandemic Vaccine Effectiveness Study
- PLoS Medicine: Effectiveness Of The 2009 Pandemic Vaccine
- Lancet: Immunogenicity and safety Of Adjuvanted Flu Vaccines
- Referral: 3 Antiviral Reports From CIDRAP
- Study: Antiviral Therapy For H5N1
- Flu Shots And The Elderly
- Study: Efficacy of Facemasks Vs. Respirators
- TCAD: A Triple Play Combination
- Cochrane Review: Vaccines And The Elderly
Widget by [ Iptek-4u ]